Target type: biologicalprocess
A process that directly activates any of the steps required for tolerance, a physiologic state in which the immune system does not react destructively against the components of an organism that harbors it or against antigens that are introduced to it. [GO_REF:0000022, GOC:jal, ISBN:0781735149]
Tolerance induction is a complex biological process that enables the immune system to recognize and respond to specific antigens while maintaining a state of non-reactivity or reduced reactivity to other antigens. It involves a delicate balance of regulatory mechanisms that prevent excessive immune responses and maintain immune homeostasis. The process of tolerance induction can be broadly classified into two main categories: central tolerance and peripheral tolerance. Central tolerance occurs during the development of immune cells in the thymus (for T cells) and bone marrow (for B cells). This process ensures that self-reactive lymphocytes are eliminated or rendered non-functional, preventing autoimmune reactions. Peripheral tolerance, on the other hand, occurs in secondary lymphoid tissues and other peripheral sites and involves mechanisms that control the activation and function of mature immune cells. Key mechanisms involved in peripheral tolerance include: 1. Anergy: This refers to the state of unresponsiveness or inactivation of lymphocytes upon encountering their specific antigen without the necessary co-stimulatory signals. 2. Suppression: Regulatory T cells (Tregs) play a critical role in suppressing the activation and function of effector T cells. Tregs express specific transcription factors and surface markers and produce immunosuppressive cytokines, effectively dampening immune responses. 3. Immune deviation: This involves the redirection of immune responses from a pro-inflammatory Th1 response to a less inflammatory Th2 response, contributing to tolerance. 4. Apoptosis: In some cases, lymphocytes encountering self-antigens can undergo programmed cell death, preventing autoimmune reactions. Tolerance induction is essential for maintaining immune homeostasis and preventing autoimmune diseases. It is a dynamic and tightly regulated process involving a complex interplay of various cellular and molecular mechanisms. While tolerance induction is crucial for preventing autoimmune responses, it also plays a role in immune responses to pathogens, ensuring that the immune system does not become hyperactive and cause tissue damage. Understanding the mechanisms of tolerance induction is critical for developing novel therapies for autoimmune diseases and other immune-related disorders.'
"
Protein | Definition | Taxonomy |
---|---|---|
C-C chemokine receptor type 4 | A C-C chemokine receptor type 4 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P51679] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
amiodarone | amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias. Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance. | 1-benzofurans; aromatic ketone; organoiodine compound; tertiary amino compound | cardiovascular drug |
clotrimazole | conazole antifungal drug; imidazole antifungal drug; imidazoles; monochlorobenzenes | antiinfective agent; environmental contaminant; xenobiotic | |
disulfiram | organic disulfide; organosulfur acaricide | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 3.1.1.1 (carboxylesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; ferroptosis inducer; fungicide; NF-kappaB inhibitor | |
itraconazole | piperazines | ||
tak 779 | |||
quercetin | 7-hydroxyflavonol; pentahydroxyflavone | antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger | |
ucb 35625 | UCB 35625: J-113863 is the (trans)-isomer; structure in first source | ||
amd 070 | mavorixafor: a derivative of AMD3100; a CXCR4 blocker | aminoquinoline |